☆ 4.6 Editorial Material

Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy

NEURO-ONCOLOGY (2022)

期刊

NEURO-ONCOLOGY

卷 24, 期 10, 页码 1658-1659

出版社

OXFORD UNIV PRESS INC

DOI: 10.1093/neuonc/noac152

关键词

-

类别

Oncology Clinical Neurology

资金

National Cancer Institute [R37CA258426]
Malnati Brain Tumor Institute

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Oncology

Ready for Prime Time? Dendritic Cells in High-Grade Gliomas

Claire A. Conarroe, Timothy N. J. Bullock

Summary: High-grade gliomas are malignant brain tumors, and despite the use of immunotherapies, patient outcomes remain poor. Dendritic cells (DC) play a crucial role in initiating an immune response against tumors, but research on their activity in high-grade gliomas is lacking. This review discusses the role of DC in the central nervous system, their infiltration in high-grade gliomas, antigen presentation, immunogenicity, and subsets involved in the antitumor immune response. It also explores the implications of suboptimal DC function in immunotherapies and opportunities for optimization in treating high-grade gliomas.

CANCERS (2023)

添加到收藏夹

Article Oncology

Dual receptor T cells mediate effective antitumor immune responses via increased recognition of tumor antigens

Hyun J. Jang, Christine Caron, Calvin K. Lee, Lu Wang, Burhan Jama, Jack D. Bui, Gerald P. Morris

Summary: The discovery that 16% of T cells naturally co-express two T-cell receptor (TCR) clonotypes prompts the examination of the role of dual TCR cells in immune functions. Using TCR alpha-reporter transgenic mice, the study tested the role of dual TCR cells in antitumor immune responses and found that they had a selective advantage in tumor responses. Dual TCR cells demonstrated an advantage in recognition of B16F10-derived neoantigens, suggesting their potential in antitumor immunotherapy.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

添加到收藏夹

Review Oncology

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy

Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou, Alan G. Ramsay

Summary: Cancers, including lymphomas, develop in complex tissue environments where malignant cells actively promote tumor growth and suppress anti-tumor immune responses. Research is revealing that the tumor microenvironment (TME) varies between different types of lymphoma, with implications for sensitivity to immunotherapies. Understanding the intricate interactions between immune-stroma lymphoma TME may help design next-generation immunotherapies to overcome TME-driven immune suppression.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

The way of interaction between Vγ9V62 T cells and tumor cells

Ting Zhang, Jiayu Wang, Anjing Zhao, Lu Xia, Haiyan Jin, Suhua Xia, Tongguo Shi

Summary: Immunotherapy using Vγ9V62 T cells, a subset of gamma 6 T cells, has shown promising results in the treatment of various cancers. These T cells interact with tumor cells through different mechanisms, such as recognition of nonpeptidic-phosphorylated phosphoantigens (pAgs), activation of the NKG2D/NKG2D ligand (NKG2DL) pathway, the Fas-FasL axis, antibody-dependent cellular cytotoxicity (ADCC) and exosomes. Clinical studies have demonstrated the safety and efficacy of Vγ9V62 T cells in cancer treatment, offering potential for new strategies in tumor immunotherapy.

CYTOKINE (2023)

添加到收藏夹

Review Oncology

Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward

Joost B. Koedijk, Inge van der Werf, Friso G. Calkoen, Stefan Nierkens, Gertjan J. L. Kaspers, Christian Michel Zwaan, Olaf Heidenreich

Summary: Immunotherapy shows promise in improving outcomes and reducing toxicity in pediatric AML, but challenges remain in its development and implementation. Understanding which patients are likely to respond to immunotherapy, and the importance of immune cell quantity and phenotype in predicting treatment efficacy, is crucial for advancing treatment options.

CANCERS (2021)

添加到收藏夹

Article Immunology

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells

Liliana E. Lucca, Pierre-Paul Axisa, Benjamin Lu, Brian Harnett, Shlomit Jessel, Le Zhang, Khadir Raddassi, Lin Zhang, Kelly Olino, James Clune, Meromit Singer, Harriet M. Kluger, David A. Hafler

Summary: Understanding the relationship between tumor and peripheral immune environments could allow longitudinal immune monitoring in cancer. Analysis of T cells from both tumor and blood in patients with metastatic melanoma revealed that circulating T cells matching clonally expanded tumor-infiltrating T cells show gene signatures of effector functions, while features of exhaustion are predominantly displayed by tumor-exclusive T cells. Circulating TILs have unique transcriptional patterns that may be useful for interrogating T cell function in cancer immunotherapy.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

添加到收藏夹

Review Immunology

Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs

Criselle D'Souza, H. Miles Prince, Paul J. Neeson

Summary: Immunomodulatory drugs have pleotropic effects on multiple myeloma treatment, targeting the myeloma cells directly and improving the anti-myeloma immune response. Combination therapies with monoclonal antibodies or checkpoint inhibitors show synergistic effects in enhancing T and NK cell dependent cellular toxicity and T cell proliferation.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas

Lawrence S. Lamb, Larisa Pereboeva, Samantha Youngblood, G. Yancey Gillespie, L. Burton Nabors, James M. Markert, Anindya Dasgupta, Catherine Langford, H. Trent Spencer

Summary: The study confirmed the significant success of using "Drug Resistant Immunotherapy" (DRI) in the treatment of glioblastoma, showing that the combination therapy of MGMT-modified gamma delta T cells with TMZ can improve survival outcomes. This method leverages the innate response of gamma delta T cells to chemotherapy-induced stress associated antigen expression, resulting in synergies significantly greater than either individual approach.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure-activity relationship

Jakub Gebalski, Filip Graczyk, Daniel Zaluski

Summary: Plants have been used for thousands of years to treat various diseases, thanks to their rich source of natural compounds with diverse biological activities. This review focuses on the anti-tyrosinase and anti-hyaluronidase activities of phytochemicals, exploring their potential applications and future prospects.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Review Immunology

Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy

M. J. Mansilla, S. Presas-Rodriguez, A. Teniente-Serra, I. Gonzalez-Larreategui, B. Quirant-Sanchez, F. Fondelli, N. Djedovic, D. Iwaszkiewicz-Grzes, K. Chwojnicki, D. Miljkovic, P. Trzonkowski, C. Ramo-Tello, E. M. Martinez-Caceres

Summary: Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to middle-aged adults, and current drug therapies are unable to halt or reverse the disease. Cell-based therapies have been proposed as a potential approach for treating MS.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment

Franziska Fuechsl, Angela M. Krackhardt

Summary: This review discusses the challenges and potential strategies for using genetically modified T cells in the treatment of solid tumors. It highlights the importance of engineering either the tumor microenvironment or the transgenic T cells themselves to achieve effective tumor control.

CANCERS (2022)

添加到收藏夹

Review Dentistry, Oral Surgery & Medicine

Evolution tumour models paving the way for understanding oral carcinogenesis

Roberta Rayra Martins-Chaves, Rubens Signoretti Oliveira Silva, Thais dos Santos Fontes Pereira, Felipe Paiva Fonseca, Ricardo Santiago Gomez

Summary: This narrative review discusses the relationship between oral epithelial dysplasia (OED) and oral potentially malignant disorders (OPMD) with oral squamous cell carcinoma (OSCC). OED and OPMD are considered precancerous lesions of OSCC, but their malignant transformation is rare. Understanding the evolution of OED is crucial for identifying potential drivers of oral carcinogenesis and molecular targets for OSCC prevention and treatment.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2023)

添加到收藏夹

Article Physics, Applied

Multi-junction solar cells paving the way for super high-efficiency

Masafumi Yamaguchi, Frank Dimroth, John F. Geisz, Nicholas J. Ekins-Daukes

Summary: High-performance solar cells, particularly multi-junction solar cells using different bandgap semiconductor materials, are considered a promising pathway towards achieving high power efficiency at low cost. III-V semiconductor materials have been shown to provide an effective system for fabricating multi-junction solar cells that can span the solar spectrum, with record efficiencies demonstrating their potential. Other materials like perovskites are also being explored for their lower manufacturing costs. The development and potential market applications of multi-junction solar cells, including III-V/Si, II-VI/Si, cadmium chalcogenide/Si, and perovskite/Si tandem solar cells, are discussed based on scientific and technological arguments.

JOURNAL OF APPLIED PHYSICS (2021)

添加到收藏夹

Editorial Material Oncology

Not All Tumor-Infiltrating CD8+ T Cells Are Created Equal

Werner Held, Daniel E. Speiser

Summary: Adoptive cell immunotherapy using in vitro expanded autologous tumor-infiltrating lymphocytes shows potential for durable remission in certain cancers, but complete and long-lasting control of metastatic melanoma requires tumor-specific CD8(+) T cells with stem-cell-like properties.

CANCER CELL (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression

Wei Jiang, Guosheng Gu, Yumin Zhang, Yushuai Song, Ming Shi, Gang Wang, Huizhong Li, Tingting Tao, Jianhua Qin, Xianliang Li, Hongtao Jia, Feng Jiao, Weidong Xu, Xiaoyi Huang

Summary: A new treatment strategy for solid tumors using a natural killer-like T cell line (UNKT) with modified chimeric antigen receptors (CAR) has been reported, showing strong antitumor activity and increased expression of effector cytokines. The CAR-UNKT cells demonstrated migration and infiltration into the tumor.

PHARMACOLOGICAL RESEARCH (2023)

添加到收藏夹

Review Medicine, Research & Experimental

New Approaches to Glioblastoma

Mustafa Khasraw, Yoko Fujita, Catalina Lee-Chang, Irina Balyasnikova, Hinda Najem, Amy B. Heimberger

Summary: With unique immunobiology and marked heterogeneity, glioblastoma treatment strategies require careful consideration of targeted and immunotherapeutic approaches. Companion biomarkers aid in selecting appropriate patient populations. Novel clinical trial strategies and innovative designs can accelerate the development and approval of effective agents.

ANNUAL REVIEW OF MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer

Alex Cordero, Matthew D. Ramsey, Deepak Kanojia, Jawad Fares, Edgar Petrosyan, Charles W. Schwartz, Rachel Burga, Peng Zhang, Aida Rashidi, Brandyn Castro, Ting Xiao, Catalina Lee-Chang, Jason Miska, Irina Balyasnikova, Atique U. Ahmed, Maciej S. Lesniak

Summary: This study engineered neural stem cells to secrete antibodies against HER2, inhibiting the progression of breast cancer brain metastases. The combination therapy with the tyrosine kinase inhibitor tucatinib showed promising results in animal models.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

添加到收藏夹

Correction Cell Biology

HIF-1α Is a Metabolic Switch Between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma (vol 27, 226-237.e1-e4, 2019)

Jason Miska, Catalina Lee-Chang, Aida Rashidi, Megan E. Muroski, Alan L. Chang, Aurora Lopez-Rosas, Peng Zhang, Wojciech K. Panek, Alex Cordero, Yu Han, Atique U. Ahmed, Navdeep S. Chandel, Maciej S. Lesniak

CELL REPORTS (2022)

添加到收藏夹

Review Oncology

Next Steps for Immunotherapy in Glioblastoma

Toni Q. Cao, Derek A. Wainwright, Catalina Lee-Chang, Jason Miska, Adam M. Sonabend, Amy B. Heimberger, Rimas Lukas

Summary: Despite current standard treatments, prognosis for glioblastoma patients remains poor. Immunotherapy, which harnesses the patient's immune system, has shown success in non-central nervous system cancers but lacks efficacy for glioblastoma. Factors impacting immunotherapy efficacy for glioblastoma have become a new focus of research.

CANCERS (2022)

添加到收藏夹

Review Oncology

Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment

Edgar Petrosyan, Jawad Fares, Luis G. Fernandez, Ragini Yeeravalli, Crismita Dmello, Joseph T. Duffy, Peng Zhang, Catalina Lee-Chang, Jason Miska, Atique U. Ahmed, Adam M. Sonabend, Irina Balyasnikova, Amy B. Heimberger, Maciej S. Lesniak

Summary: Immunotherapy has had success in halting cancer progression, but it has not been effective for primary brain malignancies, which remain a globally lethal disease. Understanding how tumor cells survive and propagate within the unique microenvironment of the central nervous system (CNS) is crucial. Cancer genetic aberrations and metabolic abnormalities lead to persistent endoplasmic reticulum (ER) stress, which promotes tumor growth, invasion, therapeutic resistance, and reprogramming of immune cells. Targeting ER stress is a potential therapeutic approach for primary CNS tumors.

MOLECULAR CANCER RESEARCH (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Crismita Dmello, Junfei Zhao, Li Chen, Andrew Gould, Brandyn Castro, Victor A. Arrieta, Daniel Y. Zhang, Kwang-Soo Kim, Deepak Kanojia, Peng Zhang, Jason Miska, Ragini Yeeravalli, Karl Habashy, Ruth Saganty, Seong Jae Kang, Jawad Fares, Connor Liu, Gavin Dunn, Elizabeth Bartom, Matthew J. Schipma, Patrick D. Hsu, Mahmoud S. Alghamri, Maciej S. Lesniak, Amy B. Heimberger, Raul Rabadan, Catalina Lee-Chang, Adam M. Sonabend

Summary: This study identifies Chek2 as the most important kinase that promotes evasion of glioma cells from immune recognition. Genetic depletion or pharmacological inhibition of Chek2 enhances antigen presentation, STING pathway activation, and PD-L1 expression, leading to survival benefits in preclinical glioma models. Analysis of human GBMs shows a negative correlation between Chek2 expression and antigen presentation/T-cell activation. These results suggest that Chek2 may be a promising target for improving response to immune checkpoint blockade therapy.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Peng Zhang, Aida Rashidi, Junfei Zhao, Caylee Silvers, Hanxiang Wang, Brandyn Castro, Abby Ellingwood, Yu Han, Aurora Lopez-Rosas, Markella Zannikou, Crismita Dmello, Rebecca Levine, Ting Xiao, Alex Cordero, Adam M. Sonabend, Irina V. Balyasnikova, Catalina Lee-Chang, Jason Miska, Maciej S. Lesniak

Summary: The study describes the use of a bridging-lipid nanoparticle (B-LNP) that engages tumor-associated myeloid cells (TAMCs) to glioblastoma cells via anti-CD47/PD-L1 dual ligation. The B-LNPs block CD47 and PD-L1, promote TAMC phagocytic activity, and enhance T cell recruitment and antitumor responses. The administration of B-LNP/diABZI combined with radiotherapy promotes brain tumor regression and induces immunological memory against glioma.

NATURE COMMUNICATIONS (2023)

添加到收藏夹

Article Oncology

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

Markella Zannikou, Joseph T. Duffy, Rebecca N. Levine, Maggie Seblani, Qianli Liu, Aaron Presser, Victor A. Arrieta, Christopher J. Chen, Adam M. Sonabend, Craig M. Horbinski, Catalina Lee-Chang, Jason Miska, Maciej S. Lesniak, Stephen Gottschalk, Irina Balyasnikova

Summary: This study found that IL15 can potentially be used to directly target myeloid-derived suppressor cells (MDSCs) in the immunosuppressive tumor microenvironment (TME) of glioblastoma (GBM). IL15-modified CAR-T cells efficiently depleted MDSCs and significantly improved survival in GBM mouse models. The results suggest that IL15-modified CAR-T cells have dual targeting effects against tumor cells and MDSCs in GBM, warranting further evaluation in early-phase clinical studies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

添加到收藏夹

Article Biochemical Research Methods

Generation of B-cell-based cellular vaccine for cancer in murine models

David Hou, Joshua L. Katz, Catalina Lee-Chang

Summary: In this article, a B-cell-based cellular vaccine (BVax) is introduced, which is able to select tumor-specific B cells and generate tumor-specific antibodies and activate T cells in ex vivo culture. The protocol for generating a B-cell-based vaccine in a CT2A orthotopic glioma murine model is described, including glioma cell implantation, tissue harvesting, 4-1BBL+ B cell isolation, and activation. The article also provides methods for assessing BVax phenotype in vitro and in vivo functional status.

STAR PROTOCOLS (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Immune checkpoint blockade in glioblastoma from tumor heterogeneity to personalized treatment

Victor A. Arrieta, Crismita Dmello, Daniel J. McGrail, Daniel J. Brat, Catalina Lee-Chang, Amy B. Heimberger, Dhan Chand, Roger Stupp, Adam M. Sonabend

Summary: Immune checkpoint blockade (ICB) has revolutionized modern cancer therapy, arousing great interest in the neuro-oncology community. While several reports show that subsets of patients with glioma exhibit durable responses to immunotherapy, the efficacy of this treatment has not been observed for unselected patient populations, preventing its broad clinical implementation for gliomas and glioblastoma (GBM).

JOURNAL OF CLINICAL INVESTIGATION (2023)

添加到收藏夹

Review Medicine, Research & Experimental

Next-generation antigen-presenting cell immune therapeutics for gliomas

Catalina Lee-Chang, Maciej S. Lesniak

Summary: Antigen presentation machinery and professional antigen-presenting cells (APCs) are crucial for an effective immune response against cancers, particularly in T cell-centric immunotherapy. Dendritic cells (DCs), the gold standard APCs, are essential in initiating and maintaining specific adaptive immunity. The use of ex vivo-differentiated DCs from circulating CD14+ monocytes loaded with tumor-associated antigens, synthetic peptides, or RNA in activating antitumor T cells has paved the way for alternative antigen-presenting vaccination strategies. This review discusses the past, present, and future of APC immune therapeutics in the context of primary brain tumors.

JOURNAL OF CLINICAL INVESTIGATION (2023)

添加到收藏夹

Meeting Abstract Oncology

LEVERAGING B CELL IMMUNITY TO PROMOTE IMMUNOTHERAPY IN GLIOBLASTOMA

David Hou, Brandyn Castro, Andrew Zolp, Mark Dapash, Victor Arrieta, Junfei Zhao, Peng Zhang, Aida Rashidi, Emma Burnham, Ronit Patel, Maciej Lesniak, Jason Miska, Catalina Lee-Chang

NEURO-ONCOLOGY (2022)

添加到收藏夹

Meeting Abstract Biotechnology & Applied Microbiology

A High Expression of IL15 Receptor Alpha (IL15Rα) in Glioblastoma Microenvironment Enables IL15-Armored CAR T Cells to Modulate Tumor Immunosuppression and Improve Survival in Syngeneic Models

Markella Zannikou, Joseph T. Duffy, Rebecca N. Levine, Maggie D. Seblani, Iris Liu, Victor A. Arrieta, Adam M. Sonabend, Catalina Lee-Chang, Jason M. Miska, Irina V. Balyasnikova

MOLECULAR THERAPY (2022)

添加到收藏夹

Correction Oncology

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma (vol 2, pg 1372, 2021)

Victor A. Arrieta, Andrew X. Chen, J. Robert Kane, Seong Jae Kang, Cynthia Kassab, Crismita Dmello, Junfei Zhao, Kirsten B. Burdett, Pavan S. Upadhyayula, Catalina Lee-Chang, Joseph Shilati, Dinesh Jaishankar, Li Chen, Andrew Gould, Daniel Zhang, Jinzhou Yuan, Wenting Zhao, Xiaoyang Ling, Jared K. Burks, Brice Laffleur, Christina Amidei, Jeffrey N. Bruce, Rimas V. Lukas, Jonathan T. Yamaguchi, David Cieremans, Gerson Rothschild, Uttiya Basu, Matthew McCord, Daniel J. Brat, Hui Zhang, Lee A. D. Cooper, Bin Zhang, Peter Sims, Tim F. Cloughesy, Robert Prins, Peter Canoll, Roger Stupp, Amy B. Heimberger, Craig Horbinski, Fabio M. Iwamoto, Raul Rabadan, Adam M. Sonabend

NATURE CANCER (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.